Why the study?
An effective RSV vaccine must elicit neutralizing antibodies and provide protection without causing vaccine-enhanced disease, and the impact of specific RSV F protein mutations in VLPs needed investigation.
Does a single dose of mutant F protein VLP induce neutralizing antibodies and confer protection against RSV without causing vaccine-enhanced disease in a cotton rat model?
Does a single dose of mutant F protein VLP induce neutralizing antibodies and confer protection against RSV without causing vaccine-enhanced disease in a cotton rat model?
A single dose of a mutant RSV F protein VLP vaccine induces neutralizing antibodies and protects against RSV without causing vaccine-enhanced disease in a preclinical cotton rat model.
Answers are grounded in this paper and cite their sources.
Promising single-dose RSV protection in cotton rats without histopathology; leaves open translation to human safety and efficacy.
An effective respiratory syncytial virus (RSV) vaccine should elicit neutralizing Abs and confer protection without causing vaccine-enhanced disease. Virus-like particle (VLP) is a safe vaccine platform that can display multivalent Ags similar to a virus and induce potent neutralizing Abs without adjuvant. We investigated the impact of mutations in the furin cleavage site, fusion (F) peptide, and change in the transmembrane (TM) domain of RSV F protein in VLPs on inducing RSV neutralizing Abs and efficacy in a cotton rat model. Palivizumab-binding antigenic site II epitope was preferentially exposed by combination mutations in the furin cleavage sites and F peptide together with a change in the TM domain. A single dose of mutant F protein VLP containing these combination mutations effectively induced IgG Ab responses to post-F and pre-F proteins, neutralizing activities, and protection without apparent lung histopathology. The VLP also induced the highest level of INF-γ, indicating the Th1-skewed immune response against the virus infection. A single dose of RSV F mutant exposing an antigenic site II on VLP vaccine could induce RSV-neutralizing Abs, conferring protection without causing vaccine-enhanced disease in cotton rats.
No takes yet. Share an insight, caveat, or question.
Hwang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: